|Articles|February 2, 2017
PAREXEL Acquires The Medical Affairs Company
PAREXEL has announced the acquisition of The Medical Affairs Company, a provider of outsourced medical affairs services to the pharma, biotech and medical device industries.
Advertisement
PAREXEL has announced the acquisition of The Medical Affairs Company, a provider of outsourced medical affairs services to the pharma, biotech and medical device industries. This acquisition provides an opportunity to reduce fixed costs for the pharma industry to address the growing commercialization-outsourcing market.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D
2
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
3
Meeting Halfway: Co-Developing Frameworks for Seamless FSO to FSP Transitions
4
SCOPE Summit 2026: ESG Shifts From Reporting Exercise to Vendor Readiness Test in Clinical Operations
5